Gusarova V

References (3)

Title : Evinacumab: Mechanism of action, clinical, and translational science - Dingman_2024_Clin.Transl.Sci_17_e13836
Author(s) : Dingman R , Bihorel S , Gusarova V , Mendell J , Pordy R
Ref : Clin Transl Sci , 17 :e13836 , 2024
Abstract :
PubMedSearch : Dingman_2024_Clin.Transl.Sci_17_e13836
PubMedID: 38845393

Title : Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance - Adam_2020_J.Lipid.Res_61_1271
Author(s) : Adam RC , Mintah IJ , Alexa-Braun CA , Shihanian LM , Lee JS , Banerjee P , Hamon SC , Kim HI , Cohen JC , Hobbs HH , Van Hout C , Gromada J , Murphy AJ , Yancopoulos GD , Sleeman MW , Gusarova V
Ref : J Lipid Res , 61 :1271 , 2020
Abstract :
PubMedSearch : Adam_2020_J.Lipid.Res_61_1271
PubMedID: 32646941

Title : ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance - Haller_2017_J.Lipid.Res_58_1166
Author(s) : Haller JF , Mintah IJ , Shihanian LM , Stevis P , Buckler D , Alexa-Braun CA , Kleiner S , Banfi S , Cohen JC , Hobbs HH , Yancopoulos GD , Murphy AJ , Gusarova V , Gromada J
Ref : J Lipid Res , 58 :1166 , 2017
Abstract :
PubMedSearch : Haller_2017_J.Lipid.Res_58_1166
PubMedID: 28413163